Literature DB >> 12422206

Tackling multiple sclerosis.

Hartmut Wekerle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12422206     DOI： 10.1038/420039a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Opinion and evidence in neurology and psychiatry.

Authors: 
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.

Authors:  R A Rudick; A Pace; M R S Rani; R Hyde; M Panzara; S Appachi; J Shrock; S L Maurer; P A Calabresi; C Confavreux; S L Galetta; F D Lublin; E-W Radue; R M Ransohoff
Journal:  Neurology       Date:  2009-06-09       Impact factor: 9.910

Review 3.  [Cholesterol-reducing medications-a new therapeutic option for multiple sclerosis? Statins as immunomodulators].

Authors:  O Neuhaus; H Wiendl; B C Kieseier; J J Archelos; H-P Hartung
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

4.  Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.

Authors:  Cindy X Zhang-Gandhi; Paul D Drew
Journal:  J Neuroimmunol       Date:  2006-12-18       Impact factor: 3.478
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.